Curing Opioid Toxicity with Intrathecal Targeted Drug Delivery
Pain is one of the most feared symptoms that concern cancer patients and their families. Despite well-established guidelines set forth by the World Health Organization (WHO) on the treatment of cancer pain, nearly half of cancer patients report poorly controlled pain. One of the most serious side ef...
Saved in:
Main Authors: | Thomas P. Pittelkow, Markus A. Bendel, Jacob J. Strand, Susan M. Moeschler |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/3428576 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dexmedetomidine as Part of a Multimodal Analgesic Treatment Regimen for Opioid Induced Hyperalgesia in a Patient with Significant Opioid Tolerance
by: Richard K. Patch III, et al.
Published: (2017-01-01) -
Efficacy and safety of single and double catheter intrathecal drug delivery systems in patients with refractory neck and abdominal cancer pain
by: Qin Li, et al.
Published: (2024-12-01) -
Targeting Drug Delivery to the Lungs by Inhalation
by: C. O'Callaghan
Published: (1994-01-01) -
Skin Closure Technique and Postprocedural Pain after Spinal Cord Stimulator Implantation: A Retrospective Review
by: Markus A. Bendel, et al.
Published: (2021-01-01) -
The method of targeted delivery of drugs to the posterior segment of the eye
by: A.E. Egorov, et al.
Published: (2018-07-01)